Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency

OBJECTIVE: This post-hoc analysis compared the lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg (EZ/Simva) versus Rosuvastatin 10 mg (Rosuva) in patients stratified by statin potency/dose prior to randomization. METHODS: Patients with elevated low-density lipoprotein cholesterol (LDL-C) des...

Descripción completa

Detalles Bibliográficos
Autores principales: Viigimaa, Margus, Vaverkova, Helena, Farnier, Michel, Averna, Maurizio, Missault, Luc, Hanson, Mary E, Dong, Qian, Shah, Arvind, Brudi, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992529/
https://www.ncbi.nlm.nih.gov/pubmed/21050476
http://dx.doi.org/10.1186/1476-511X-9-127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992529/
https://www.ncbi.nlm.nih.gov/pubmed/21050476
http://dx.doi.org/10.1186/1476-511X-9-127

Ejemplares similares